Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q1 EPS of ($0.08), $0.17 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.